Pharmacotherapy used for alcohol and cocaine use disorders in a CAPS-AD of Minas Gerais
Braz. J. Pharm. Sci. (Online)
; 58: e19702, 2022. tab
Article
em En
| LILACS
| ID: biblio-1394037
Biblioteca responsável:
BR40.1
Localização: BR40.1
ABSTRACT
Abstract Substance use disorder is one of the major social and public health problems in the world. The present study analyzed the pharmacoepidemiological profile of patients treated at the Psychosocial Treatment Center for Alcohol and Substance Use Disorders (CAPS-AD) for treatment of alcohol use disorders (AUD), cocaine use disorders (CUD) and concomitant alcohol and cocaine use disorders (A-CUD) in the city of Betim-MG. The study used quantitative and descriptive data and was based on the evaluation of medical records of patients attended from January to December 2016. After analyzing 295 medical records, the majority of study participants were male (83.7 %) with an average age of 46.26 for AUD, 28.88 for CUD and 34.29 for A-CUD. The most prescribed drugs for AUD were diazepam (54.1 %), thiamine (37 %), complex B vitamins (29.5 %), and disulfiram (2.7 %); for CUD, diazepam (26.9 %) and haloperidol (23.1 %). It should be noticed that although contraindicated by the guidelines, chlorpromazine (42.3 %, 25.3 %, 20.3 %) was prescribed for CUD, AUD, and A-CUD respectively. Knowing the pharmacoepidemiological profile of CAPS-AD patients is extremely important for making decisions regarding which medicines to make available to the population.
Palavras-chave
Texto completo:
1
Base de dados:
LILACS
Assunto principal:
Transtornos Relacionados ao Uso de Substâncias
/
Transtornos Relacionados ao Uso de Álcool
/
Transtornos Relacionados ao Uso de Cocaína
/
Tratamento Farmacológico
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article